Abstract:Self-assembling complexes from nucleic acids and synthetic polymers are evaluated for plasmid and oligonucleotide (oligo) delivery. Polycations having linear, branched, dendritic. block- or graft copolymer architectures are used in these studies. All these molecules bind to nucleic acids due to formation of cooperative systems of salt bonds between the cationic groups of the polycation and phosphate groups of the DNA. To improve solubility of the DNA/polycation complexes, cationic block and graft copolymers containing segments from polycations and non-ionic soluble polymers, for example, poly(ethylene oxide) (PEO) were developed. Binding of these copolymers with short DNA chains, such as oligos, results in formation of species containing hydrophobic sites from neutralized DNA polycation complex and hydrophilic sites from PEO. These species spontaneously associate into polyion complex micelles with a hydrophobic core from neutralized polyions and a hydrophilic shell from PEO. Such complexes are very small (10-40 nm) and stable in solution despite complete neutralization of charge. They reveal significant activity with oligos in vitro and in vivo. Binding of cationic copolymers to plasmid DNA forms larger (70-200 nm) complexes. which are practically inactive in cell transfection studies. It is likely that PEO prevents binding of these complexes with the cell membranes ("stealth effect"). However attaching specific ligands to the PEO-corona can produce complexes, which are both stable in solution and bind to target cells. The most efficient complexes were obtained when PEO in the cationic copolymer was replaced with membrane-active PEO-b-poly(propylene oxide)-b-PEO molecules (Pluronic 123). Such complexes exhibited elevated levels of transgene expression in liver following systemic administration in mice. To increase stability of the complexes, NanoGel carriers were developed that represent small hydrogel particles synthesized by cross-linking of PEI with double end activated PEO using an emulsification/solvent evaporation technique. Oligos are immobilized by mixing with NanoGel suspension, which results in the formation of small particles (80 nm). Oligos incorporated in NanoGel are able to reach targets within the cell and suppress gene expression in a sequence-specific fashion. Further. loaded NanoGel particles cross-polarized monolayers of intestinal cells (Caco-2) suggesting potential usefulness of these systems for oral administration of oligos. In conclusion the approaches using polycations for gene delivery for the design of gene transfer complexes that exhibit a very broad range of physicochemical and biological properties, which is essential for design of a new generation of more effective non-viral gene delivery systems.

Gene delivery to mammalian cells using a graphene nanoribbon platform

Precision-Guided Nanospears for Targeted and High-Throughput Intracellular Gene Delivery.

Untying a Nanoscale Knotted Polymer Structure to Linear Chains for Efficient Gene Delivery in Vitro and to the Brain

Gene-encoding DNA origami for mammalian cell expression

High aspect ratio graphene oxide: a highly efficient plasmid DNA deliverer for plant seed

GDNF gene delivery via a 2-(dimethylamino)ethyl methacrylate based cyclized knot polymer for neuronal cell applications.

GFP Plasmid and Chemoreagent Conjugated with Graphene Quantum Dots as a Novel Gene Delivery Platform for Colon Cancer Inhibition In Vitro and In Vivo

Biodegradable silica nanoparticles for efficient linear DNA gene delivery

Block and graft copolymers and NanoGel copolymer networks for DNA delivery into cell

DNA origami drives gene expression in a human cell culture system

Nano-delivery platforms for bacterial gene transformation: suitability and challenges

Biocompatible Multi-Walled Carbon Nanotube-Chitosan-Folic Acid Nanoparticle Hybrids As Gfp Gene Delivery Materials

Nano-Graphene Oxide for Cellular Imaging and Drug Delivery

The Use of Polyethylenimine-Grafted Graphene Nanoribbon for Cellular Delivery of Locked Nucleic Acid Modified Molecular Beacon for Recognition of Microrna

In vitro assessments of nanoplexes of polyethylenimine-coated graphene oxide-plasmid through various cancer cell lines and primary mesenchymal stem cells

Gene Delivery With Nanofibrous Scaffolds

Efficient Non-Viral Gene Delivery Mediated By Nanostructured Calcium Carbonate In Solution-Based Transfection And Solid-Phase Transfection

Mechanical stretching of cells and lipid nanoparticles for nucleic acid delivery

Polyethylenimine-functionalized graphene oxide as an efficient gene delivery vector

Terminal Pegylated Dna-Gold Nanoparticle Conjugates Offering High Resistance to Nuclease Degradation and Efficient Intracellular Delivery of Dna Binding Agents

Graphene Quantum Dots for siRNA Delivery in Gene Silencing Cancer Therapy